Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$372,089
-$14,322,592 QoQ
Shares Held
6,401
-97.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#207
of 329 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Derivatives in PCVX
reported options exposure · as of Jun 30, 2026CallValue
$14,881,280
CallShares
256,000
PutValue
$35,162,837
PutShares
604,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,130,252 across 291 Biotechnology names. PCVX ranks #132 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in PCVX
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,162,837 | 604,900 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $372,089 | 6,401 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $14,881,280 | 256,000 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $33,308,652 | 573,200 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $14,694,681 | 252,877 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $13,650,039 | 234,900 | Call | Defined | 2026-05-12 | |
| 2025-12-31 | $1,305,762 | 28,300 | Put | Defined | 2026-02-12 | |
| 2025-12-31 | $226,086 | 4,900 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $12,900,927 | 279,604 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $12,379,965 | 343,697 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $2,744,724 | 76,200 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $443,046 | 12,300 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $9,679,786 | 297,748 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $617,690 | 19,000 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $320,960 | 8,500 | Put | Defined | 2025-05-19 | |
| 2025-03-31 | $5,489,887 | 145,389 | Shares | Defined | 2025-05-19 | |
| 2025-03-31 | $1,940,864 | 51,400 | Call | Defined | 2025-05-19 | |
| 2024-12-31 | $2,906,030 | 35,500 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $1,023,250 | 12,500 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $24,500,042 | 299,292 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,468,232 | 21,600 | Put | Defined | 2024-11-15 | |
| 2024-09-30 | $9,774,997 | 85,543 | Shares | Defined | 2024-11-15 | |
| 2024-09-30 | $8,364,564 | 73,200 | Call | Defined | 2024-11-15 | |
| 2024-06-30 | $8,050,195 | 106,611 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $1,071,237 | 15,682 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $4,391,478 | 69,928 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $3,632,285 | 72,733 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $742,628 | 19,814 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $386,524 | 8,061 | Shares | Defined | 2023-02-15 | |
| 2020-09-30 | $396,422 | 8,028 | Shares | Defined | 2020-11-17 | |
| 2020-06-30 | $422,941 | 13,380 | Shares | Defined | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||